Bentham Science Logo

Current Pharmaceutical Biotechnology

Volume 20, 15 Issues, 2019
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access

Ranking and Category

  • 259th of 298 in

    Biochemistry & Molecular Biology

  • 219th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Editor's Choice

Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.

“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”

Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.

Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples:













Factors Regulating Human Extravillous Trophoblast Invasion: Chemokine-peptidase and CD9-integrin Systems

, 2018; 19(10): 764 - 770

Hiroshi Fujiwara*, Hisanori Matsumoto, Yukiyasu Sato, Akihito Horie, Masanori Ono, Mitsuhiro Nakamura, Yasunari Mizumoto, Kyosuke Kagami, Tomoko Fujiwara, Akira Hattori, Yoshiko Maida, Takiko Daikoku, Kazuhiko Imakawa and Yoshihiko Araki


DOI: 10.2174/1389201019666181029164906






Perspectives of Nanoemulsion Strategies in The Improvement of Oral, Parenteral and Transdermal Chemotherapy

, 2018; 19(4): 276 - 292

Manisha Pandey*, Hira Choudhury, Ong C. Yeun, Hoh M. Yin, Tan W. Lynn, Celine L.Y. Tine, Ng S. Wi, Kelly C.C. Yen, Cheng S. Phing, Prashant Kesharwani, Subrat K. Bhattamisra and Bapi Gorain*


DOI: 10.2174/1389201019666180605125234
















Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital

, 2017; 18(3): 274 - 281

Raffaele La Russa, Vittorio Fineschi, Mariantonia Di Sanzo, Vittorio Gatto, Alessandro Santurro*, Gabriella Martini, Matteo Scopetti and Paola Frati


DOI: 10.2174/1389201018666170207124835



Personalized Medicine Applied to Forensic Sciences: New Advances and Perspectives for a Tailored Forensic Approach

, 2017; 18(3): 263 - 273

Alessandro Santurro, Anna Maria Vullo, Marina Borro, Giovanna Gentile, Raffaele La Russa, Maurizio Simmaco, Paola Frati* and Vittorio Fineschi


DOI: 10.2174/1389201018666170207141525


Personalised Healthcare: The DiMA Clinical Model

, 2017; 18(3): 242 - 252

Marina Borro, Giovanna Gentile, Luigi Cipolloni, Zeno Foldes-Papp, Paola Frati, Alessandro Santurro, Luana Lionetto and Maurizio Simmaco*


DOI: 10.2174/1389201018666170208125131



Clinical Applications of Personalized Medicine: A New Paradigm and Challenge

, 2017; 18(3): 194 - 203

Mariantonia Di Sanzo, Luigi Cipolloni, Marina Borro, Raffaele La Russa, Alessandro Santurro, Matteo Scopetti, Maurizio Simmaco and Paola Frati


DOI: 10.2174/1389201018666170224105600






Confocal Fluctuation Spectroscopy and Imaging

, 2010; 11(6): 639 - 653

Zeno Foldes-Papp, Shih-Chu Jeff Liao, Tiefeng You, Ewald Terpetschnig and Beniamino Barbieri


DOI: 10.2174/138920110792246618













Single-Quantum Dot Imaging with a Photon Counting Camera

, 2009; 10(5): 543 - 557

X. Michalet, R. A. Colyer, J. Antelman, O. H.W. Siegmund, A. Tremsin, J. V. Vallerga and S. Weiss


DOI: 10.2174/138920109788922100































Moderate Hyperhomocysteinemia and Immune Activation

, 2004; 5(1): 107 - 118

K. Schroecksnadel, B. Frick, B. Wirleitner, C. Winkler, H. Schennach and D. Fuchs


DOI: 10.2174/1389201043489657






Virus Diagnostics on Microarrays

, 2003; 4(6): 401 - 415

Hans-Martin Striebel, Eckhard Birch-Hirschfeld, Renate Egerer and Zeno Foldes-Papp


DOI: 10.2174/1389201033377274









Editor-in-Chief

Davide Prosperi
Department of Biotechnology and Bioscience
University of Milano-Bicocca
Milano
Italy

Biography View Full Editorial Board

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Davide Prosperi serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog